Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sickle-Cell; Hemoglobin Disease, Thalassemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01319851
What this trial is testing

Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
ThalassemiaSickle Cell DiseaseGlanzmann Thrombasthenia+10 more
Emory University 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT02105766
What this trial is testing

Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure

Who this might be right for
Sickle Cell DiseaseThalassemiaStem Cell Transplantation+1 more
National Heart, Lung, and Blood Institute (NHLBI) 56
Not applicableTemporarily Not AvailableNCT07640815
What this trial is testing

Expanded Access Protocol for Gene Therapy Utilizing shmiR Lentivirus Vector to Induce Fetal Hemoglobin in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
David Williams
Not applicableStudy completedNCT04678037
What this trial is testing

Home-based Assessment of PRO Measures in SCD Using A Smartphone App Platform: A Feasibility Study

Who this might be right for
Sickle Cell DiseaseSickle Cell Hemoglobin CSickle Beta Zero Thalassemia+1 more
Ann & Robert H Lurie Children's Hospital of Chicago 40
Not applicableEnrolling By InvitationNCT06664541
What this trial is testing

Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy

Who this might be right for
Transfusion Dependent Beta ThalassemiaSickle Cell Disease
Georgetown University 100
Testing effectiveness (Phase 2)Study completedNCT00125788
What this trial is testing

L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia

Who this might be right for
Sickle Cell AnemiaThalassemia
Emmaus Medical, Inc. 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT00061568
What this trial is testing

Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias

Who this might be right for
Congenital Hemolytic AnemiaSickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 130
Early research (Phase 1)Study completedNCT01522547
What this trial is testing

Study to Determine the Maximum Tolerated Dose, Safety and Effectiveness of Pomalidomide for Patients With Sickle Cell Disease

Who this might be right for
Anemia, Sickle Cell
Celgene 12
Large-scale testing (Phase 3)UnknownNCT02604368
What this trial is testing

A Sickle CEll Disease ComplicatioN Trial

Who this might be right for
Sickle Cell Disease
Micelle BioPharma Inc 210
Not applicableStudy completedNCT02242058
What this trial is testing

QST-Pupillometry in Sickle Cell Disease Patients

Who this might be right for
SCD With Severe Phenotype (HbSS, HbSβ0 Thalassemia, HbSOARab)
Julia Finkel 96
Early research (Phase 1)Study completedNCT06581627
What this trial is testing

A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants

Who this might be right for
Healthy VolunteersSickle Cell DiseaseThalassemia
Novo Nordisk A/S 24
Not applicableStudy completedNCT01715480
What this trial is testing

Effect of Broccoli Sprouts Homogenate on SS RBC

Who this might be right for
Sickle Red Blood CellFetal HemoglobinOxidative Stress
Duke University 21
Not applicableStudy completedNCT02197845
What this trial is testing

Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators

Who this might be right for
Sickle Cell Disease
Virginia Commonwealth University 353
Testing effectiveness (Phase 2)Study completedNCT00004412
What this trial is testing

Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers

Who this might be right for
Skin UlcersSickle Cell Anemia
Susan P. Perrine 23
Very early researchNot Yet RecruitingNCT07190001
What this trial is testing

YOLT-204 in Patients With Hemoglobinopathies

Who this might be right for
Hemoglobinopathies (Transfusion-dependent β-thalassemia and Sickle Cell Disease)
Guangzhou Women and Children's Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00957931
What this trial is testing

Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs

Who this might be right for
Sickle Cell DiseaseThalassemiaDiamond-Blackfan Anemia
Stanford University 6
Not applicableStudy completedNCT01572922
What this trial is testing

Massive Iron Deposit Assessment

Who this might be right for
Iron OverloadExcessive Body Iron Burden
St. Jude Children's Research Hospital 142
Large-scale testing (Phase 3)Looking for participantsNCT06609226
What this trial is testing

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

Who this might be right for
Sickle Cell DiseaseThalassemia
Novo Nordisk A/S 480
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableUnknownNCT01201135
What this trial is testing

GDF 15 in Sickle Cell Disease and Hereditary Spherocytosis

Who this might be right for
Patients With Thalassemia Intermedia,Congenital Dyserythropoietic Anemia Type I
Wolfson Medical Center 80
Next Page